Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
13
×
life sciences
vc
13
×
venture capital
13
×
national blog main
san diego blog main
national top stories
san diego top stories
san francisco blog main
boston blog main
new york blog main
raleigh-durham blog main
boston top stories
indiana blog main
seattle blog main
startups
texas blog main
boulder/denver blog main
detroit blog main
raleigh-durham top stories
wisconsin blog main
boulder/denver top stories
cancer
deals
detroit top stories
indiana top stories
ipo
national
new york top stories
san francisco top stories
seattle top stories
texas top stories
wisconsin top stories
celgene
fda
funding
gene editing
san diego
bio
biogen
What
bio
roundup
life
new
san
science
ipo
million
advance
billions
biology
capital
companies
cytokine
developing
diego
diego’s
dollars
driven
drugs
economic
enhanced
fund
health
healthcare
hundreds
impact
investors
medical
medicine
partners
patients
plans
suite
synthetic
synthorx
venture
abbvie’s
activity
additional
Language
unset
Current search:
vc
×
" venture capital "
×
biotech
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Hatteras Launches New Fund With $94M for Life Science Investments
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@xconomy.com
5 years ago
RiverVest Venture Closes $184M Fund for Backing Healthcare Ventures
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@xconomy.com
5 years ago
Nominations Open for San Diego’s Inaugural Xconomy Awards
@techcrunch.com
5 years ago
China is funding the future of American biotech
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
In Boston’s Shadow, Rhode Island Fights for Life Science Jobs, Respect
@xconomy.com
6 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs